Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant human co-stimulatory molecule bacilli-calmette-guerin strain and process for making same

A technology of molecular BCG and co-stimulatory molecules, which is applied in the field of genetic engineering, can solve problems such as no BCG strains, and achieve the effect of reducing dosage and reducing toxic and side effects

Active Publication Date: 2005-12-07
天津市泌尿外科研究所 +4
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are studies on the transfer of other cytokine genes into BCG at home and abroad, but there is no BCG strain that uses co-stimulatory molecules to form a dual stimulation signal for treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant human co-stimulatory molecule bacilli-calmette-guerin strain and process for making same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] 1. Materials

[0025] (1) Bacterial strain: Escherichia coli is DH5α, which is preserved in our institute. BCG was purchased from Beijing Institute of Biological Products, Denmark type I.

[0026] (2) Plasmid: The vector plasmid pYL-hIFN-α-2B plasmid was provided by Professor YI LUO of Iowa University, USA. The huB7-2(IgV+C) / pGEX-4T-3 plasmid containing hB7-2 cDNA was provided by Mr. Lai Baochang from Xi'an Medical University.

[0027] (3) Main instruments and equipment

[0028] 1. Microplate reader: SUNRISE TECAN A-5082 Austria

[0029] 2. Constant temperature incubator and desktop centrifuge:

[0030] 3. Low temperature and high speed centrifuge: BECKMAN J2-HS USA

[0031] 4. PCR instrument: PERKIN ELEMER GeneAmp PCR System 2400 USA

[0032] 5. Electroporator: Genepulser Electroprotocol, USA

[0033] (4) Preparation of main reagents and solutions

[0034] 1. Gel Extraction Kit: E.Z.N.A Gel Extraction Kit

[0035] 2. Purification Kit: TaKaRa DNA Fragment Purif...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a recombinant human co-stimulatory molecule bacilli-calmette-guerin strain and process for preparation, wherein the cultrue preservation number is CGMCC No.1120. The preparing process consists of carrying out hB7-2(IgC+IgV) fragment polymerase chain reaction, establishing plasmid pYL-hB7-2 and transforming, carrying out E.Coli-pYL-hB7-2 monoclonal bacterial colony expansion, plasmid extraction and purification, electrophoresis, enzyme cutting and determination of pYL-hB7-2 plasmid through PCR reaction, bacillus Calmette-Guerin vaccine electrical transformation, rBCG-hB7-2 monoclonal bacterial colony selection, expansion, and determination.

Description

technical field [0001] The invention relates to genetic engineering technology, in particular to a recombinant human co-stimulatory molecule Bacillus Calmette-Guerin strain and a preparation method thereof. Background technique [0002] Bacillus Calmette-Guerin (BCG) is a highly virulent biological immunomodulator formed by attenuated Mycobacterium bovis, which has a high degree of safety and few serious complications, and is widely used in the prevention of tuberculosis all over the world. [0003] Intravesical infusion of wild-type BCG has achieved satisfactory clinical efficacy in the prevention of tumor recurrence, treatment of residual tumors and carcinoma in situ, but 30-45% of patients still do not respond to intracavitary BCG infusion therapy. Endo-BCG perfusion can cause local and systemic reactions in the bladder, 5% of patients may have serious complications, and 0.5% may even be life-threatening, which limits the prevention and treatment of superficial bladder tu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/21
Inventor 韩瑞发王靖宇姚智刘春雨马腾骧
Owner 天津市泌尿外科研究所
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com